Effect of periodontal treatment in patients with periodontitis and diabetes: systematic review and meta-analysis.
Mauricio Baeza, Alicia Morales, Carlos Cisterna...
https://pubmed.ncbi.nlm.nih.gov/31939522Actively Recruiting
Phase Not Applicable
Age: 18Years +
All Genders
ID06895980
Effect of Periodontal Treatment on Metabolic Control in Patients with Type-2 Diabetes Mellitus Treated in the Cardiovascular Health Program
Led by University of Chile · Updated on 2025-03-26
80
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial investigates how periodontal treatment affects glycated hemoglobin (HbA1c) levels in adults with type 2 diabetes and periodontitis. It aims to understand whether treating gum disease can help control blood sugar and improve quality of life in patients enrolled in the Cardiovascular Health Program. Participants will receive non-surgical periodontal treatment followed by maintenance therapy at 3, 6, 9, and 12 months. Alongside treatment, researchers will measure HbA1c levels and collect quality of life data using the OHIP-14SP oral health survey at these same intervals. Throughout the 13-month study, participants will undergo regular periodontal evaluations measuring probing depth, clinical attachment loss, and bleeding on probing. The study will track changes in HbA1c and quality of life to assess treatment impact. Participants can expect periodic clinical assessments and surveys during their involvement.
CONDITIONS
Brief Title
Effect of Periodontal Treatment on Metabolic Control in Patients with Type-2 Diabetes Mellitus Treated in the Cardiovascular Healt Program
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Patients enrolled in the Cardiovascular Health Program with a diagnosis of type 2 diabetes mellitus and glycated hemoglobin of 7% or higher within the last 6 months
- Patients diagnosed with periodontitis having clinical attachment loss on two or more non-adjacent teeth or attachment loss of 3mm or more with probing depth of 3mm or more on at least two teeth, not due to other causes
You will not qualify if you...
- Patients who have received periodontal treatment in the past year
- Pregnant or breastfeeding women
- Patients treated with antibiotics or non-steroidal anti-inflammatory drugs in the last 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - 12 months
Participants receive non-surgical periodontal treatment with periodontal maintenance therapy at 3, 6, 9, and 12 months, along with measurement of glycated hemoglobin and application of the OHIP-14SP oral health-related quality of life survey at each time point.
1 initial treatment visit and 4 follow-up visits at 3, 6, 9, and 12 months
Trial Site Locations
Total: 1 location
1
Universidad de Chile
Santiago, Providencia, Chile
Actively Recruiting
Loading map...
Research Team
M
Melisa Vera, Specialist in periodontics
J
Jorge Gamonal, Specialist in periodontics
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing.
Charles M Cobb
https://pubmed.ncbi.nlm.nih.gov/12010523